(provided by the applicant): Continuing support is requested for years 35-40 of the Yale Predoctoral Training Program in Human Genetics and Genomics. The program involves 49 trainers from 15 departments. The vast majority of trainers are primary and joint appointees in the Department of Genetics at the School of Medicine, and virtually all of the trainees over the last funding period have been matriculated in the Molecular Cell Biology, Genetics &Development Track (MCGD) in Biological and Biomedical Sciences at Yale. The focus of the training proposed is the use of genetic and genomic approaches to understand human disease. The main methods used are newly developed next generation sequencing methods for human trait locus discovery, complemented by bioinformatics and computational analysis. An emphasis of the program is integration with model system genetics and genomics, which can be used to define pathways that link gene mutations to disease phenotypes. To this end, investigators performing genetic and genomic analysis of flies, worms, zebrafish, mouse and induced pluripotent stem cells play a major role in this Training Grant. This integrated training environment is intended to provide trainees with broad exposure to genetics and genomics and a rich training environment that prepares them for careers in science. Admitted students have strong scientific backgrounds and research experience with high academic achievement. First year students are supported by Yale;students are supported by the training grant in years 2 and 3, and thereafter by funds in Training Faculty laboratories until graduation. Training in the first year includes formal course work and research rotations, leading to selection of the thesis advisor and laboratory. In the second year, students complete course work, and take a qualifying exam in which they must demonstrate mastery of genetics and defend two written research proposals. Subsequent years are devoted to dissertation research, development of experimental and analytic skills, along with ability in written and oral presentation, leading to preparation of the written thesis. In addition, students engage in supervised teaching experiences. Support is requested for 5 years for support of 7 Ph.D. students per year who are in years 2 and 3 of their training. Outcomes of trainees are documented and indicate high success in completion of the Ph.D., publication of work in high impact journals, and continuation in science of the vast majority of graduating students.

Public Health Relevance

The identification of specific DNA mutations that cause human disease is revolutionizing medicine by leading to new insights into disease pathogenesis, allowing new approaches to the prevention, diagnosis and treatment of disease. The pace of this research is accelerating with development of methods to rapidly and inexpensively sequence all the human genes and to quickly determine the impact of identified mutations by studies in model organism and simple cell-based systems. This training program will train the next generation of scientists to be able to take full advantage of these new technologies and prepare them for productive careers in science that will lead to improved human health.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Institutional National Research Service Award (T32)
Project #
5T32HD007149-37
Application #
8708172
Study Section
Special Emphasis Panel (ZHD1-DRG-D (RL))
Program Officer
Parisi, Melissa
Project Start
1978-07-01
Project End
2018-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
37
Fiscal Year
2014
Total Cost
$317,451
Indirect Cost
$15,219
Name
Yale University
Department
Genetics
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Sondalle, S B; Baserga, S J; Yelick, P C (2016) The Contributions of the Ribosome Biogenesis Protein Utp5/WDR43 to Craniofacial Development. J Dent Res 95:1214-20
Griffin, John N; Sondalle, Samuel B; Del Viso, Florencia et al. (2015) The ribosome biogenesis factor Nol11 is required for optimal rDNA transcription and craniofacial development in Xenopus. PLoS Genet 11:e1005018
Yartseva, Valeria; Giraldez, Antonio J (2015) The Maternal-to-Zygotic Transition During Vertebrate Development: A Model for Reprogramming. Curr Top Dev Biol 113:191-232
Sharon, Donald; Tilgner, Hagen; Grubert, Fabian et al. (2013) A single-molecule long-read survey of the human transcriptome. Nat Biotechnol 31:1009-14
Richardson, Lauren A; Reed, Benjamin J; Charette, J Michael et al. (2012) A conserved deubiquitinating enzyme controls cell growth by regulating RNA polymerase I stability. Cell Rep 2:372-85
Magaldi, Thomas G; Almstead, Laura L; Bellone, Stefania et al. (2012) Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology 422:114-24
Freed, Emily F; Prieto, Jose-Luis; McCann, Kathleen L et al. (2012) NOL11, implicated in the pathogenesis of North American Indian childhood cirrhosis, is required for pre-rRNA transcription and processing. PLoS Genet 8:e1002892
Magaldi, Thomas G; Buch, Michael H C; Murata, Haruhiko et al. (2012) Mutations in the GM1 binding site of simian virus 40 VP1 alter receptor usage and cell tropism. J Virol 86:7028-42
Freed, Emily F; Baserga, Susan J (2010) The C-terminus of Utp4, mutated in childhood cirrhosis, is essential for ribosome biogenesis. Nucleic Acids Res 38:4798-806
Freed, Emily F; Bleichert, Franziska; Dutca, Laura M et al. (2010) When ribosomes go bad: diseases of ribosome biogenesis. Mol Biosyst 6:481-93

Showing the most recent 10 out of 22 publications